Tenax Therapeutics (TENX) Posts Q2 Loss of 14c/Share

Tenax Therapeutics (NASDAQ: TENX) reported Q2 EPS of ($0.14), $0.04 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Tenax Therapeutics (TENX) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Netflix, Intuitive Surgical tumble premarket
• Taiwan Semi (TSM) PT Raised to $500 at DA Davidson Following Q2 Earnings, Revenue Beat